Business | Published:

Copycats gear up to dog biotech brands

Nature volume 443, pages 496497 (05 October 2006) | Download Citation


Pressure is mounting on US regulators to create an approval track for generic versions of biotechnology drugs. Meredith Wadman reports.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

About this article

Publication history




  1. Search for Meredith Wadman in:


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing